Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients (Q113911442)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients |
clinical trial |
Statements
Pharmacogenetic Risk Factors of Doxorubicin-Cyclophosphamide Chemotherapy Related Toxicities in Breast Cancer Patients (English)
0 references
15 October 2020
0 references
15 December 2020
0 references
100
0 references
18 year
0 references
75 year
0 references